LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $26,852,000 | +87.8% | 270,000 | +80.0% | 0.34% | +29.4% |
| Q3 2020 | $14,298,000 | +6.5% | 150,000 | +25.0% | 0.26% | +4.0% |
| Q2 2020 | $13,422,000 | -19.8% | 120,000 | -47.8% | 0.25% | -67.2% |
| Q1 2020 | $16,726,000 | -2.8% | 230,000 | +39.4% | 0.77% | +64.8% |
| Q4 2019 | $17,209,000 | -40.4% | 165,000 | -43.1% | 0.47% | -28.1% |
| Q3 2019 | $28,867,000 | -39.2% | 290,000 | -17.1% | 0.65% | -53.0% |
| Q4 2018 | $47,495,000 | – | 350,001 | – | 1.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |